세계의 대사 검사 시장 : 북미가 시장을 견인하고, 아시아가 그 뒤를 이을 것

Report Scope:

The latest market report by Persistence Market Research on the global metabolic testing market evaluates the opportunities and current market scenario, providing insights and updates about corresponding segments involved in the market for the forecast period of 2022-2032. The report provides a detailed assessment of key market dynamics and comprehensive information about the structure of the market. This study contains detailed insights into how the market is anticipated to grow during the forecast period of 2022-2032.

The primary objective of the report is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with metabolic testing. It is very important to consider that, in an ever-wavering economy, we provide estimated (Y-o-Y) year-on-year growth rate in addition to the compound annual growth rate (CAGR) for overall forecasts, to enable readers better understand the analysis and evaluation of the market, and to discover lucrative opportunities in this space.

This report also provides an estimate of market size and corresponding revenue forecasts carried out in terms of absolute $ opportunity. It also offers actionable insights based on future trends in the market. Furthermore, new and emerging players in the global metabolic testing market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global market.

The study is relevant for manufacturers, suppliers, distributors, and investors in the metabolic testing market. All stakeholders, as well as industry experts, researchers, journalists, and business researchers can leverage the information and data represented in the report.

Key Market Segments

Persistence Market Research's report on the global metabolic testing market offers information divided into five segments - product, application, technology, end user, and region.

Product

CPET Systems

Metabolic Carts

Body Consumption Analyzers

ECGs/EKGs Attachable to CPET Systems

Software

Application

Lifestyle Diseases

Critical Care

Human Performance Testing

Dysmetabolic Syndrome X

Metabolic Disorders

Other Applications

Technology

VO2 Max Analysis

RMR Analysis

Body Composition Analysis

End User

Hospitals

Laboratories

Sports Training Centers

Gyms

Other End Users

Region

North America

Europe

Latin America

East Asia

The Middle East & Africa

South Asia & Pacific

Key Questions Answered in Study

Which region will hold the highest market share over the forecast period?

Which region is experiencing the highest growth (CAGR)?

Which factors are impacting the global metabolic testing industry?

What are the global trends impacting the market?

What strategies must emerge players adopt to capture opportunities in various regions in the market?

What is the structure of the global metabolic testing market?

Research Methodology

Persistence Market Research is committed to providing unbiased market research solutions to its clients. The company follows a robust methodology for the deduction of data included in this report. A unique research methodology is utilized to conduct extensive research on the global metabolic testing market, and reach conclusions about the future growth factors of the market. The research methodology comprises primary research methods coupled with secondary research methods, which ensures the accuracy and reliability of the conclusions in this report.

A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period.

This methodology is based on standard market structures, methods, and definitions that are based on inputs from local sources in over six regions - North America, Latin America, Europe, South Asia and Pacific, East Asia, and the Middle East & Africa, which Persistence Market Research considers for segmenting the global market. Statistics, characteristics, and variances are collected at a regional level, aggregated at the same level, and then synthesized at a worldwide level, to create global market measurements.

Our main sources of research include:

Primary Research

Secondary Research

Trade Research

Social Media Research

Table of Contents

1. Executive Summary

• 1.1. Global Market Overview
• 1.2. Summary of Key Statistics
• 1.3. Summary of Key Findings
• 1.4. Product Evolution Analysis
• 1.5. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage/Taxonomy
• 2.2. Market Definition/Scope/Limitations

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Future Prospects of Metabolic Testing Industry
  • 3.2.1. Factors Fuelling Growth
  • 3.2.2. Influx of Brands
  • 3.2.3. Innovative Distribution & Marketing Strategies

4. Rules and Regulations

5. Global Metabolic Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032

• 5.1. Historical Market Volume ('000 Units) Analysis, 2017-2021
• 5.2. Current and Future Market Volume ('000 Units) Projections, 2022-2032
• 5.3. Y-o-Y Growth Trend Analysis

6. Global Metabolic Testing Market - Pricing Analysis

• 6.1. Pricing Analysis By Product
• 6.2. Global Average Pricing Analysis Benchmark

7. Global Metabolic Testing Market Demand (in Value or Technology in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

• 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

• 8.1. Global Metabolic Testing industry Outlook
• 8.2. Macro-Economic Factors
  • 8.2.1. GDP Growth Outlook
  • 8.2.2. Consumer Spending Outlook
  • 8.2.3. GDP Growth Rate Analysis
  • 8.2.4. Income Group Population Overview
  • 8.2.5. Per Capita Disposable Income
• 8.3. Forecast Factors - Relevance & Impact
  • 8.3.1. Top Companies Historical Growth
  • 8.3.2. Urbanization Growth Outlook
  • 8.3.3. Others
• 8.4. PESTLE Analysis of Global Metabolic Testing Market
• 8.5. Investment Feasibility Matrix of Metabolic Testing Market
• 8.6. Porter's Five Forces Analysis of Global Metabolic Testing Market
• 8.7. Market Dynamics
  • 8.7.1. Drivers
  • 8.7.2. Restraints
  • 8.7.3. Opportunity Analysis

9. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Product, 2017 - 2021
• 9.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Product, 2022 - 2032
  • 9.3.1. CPET Systems
  • 9.3.2. Metabolic Carts
  • 9.3.3. Body Consumption Analyzers
  • 9.3.4. ECGs/EKGs Attachable to CPET Systems
  • 9.3.5. Software
• 9.4. Market Attractiveness Analysis by Product

10. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Application

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Application, 2017 - 2021
• 10.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Application, 2022 - 2032
  • 10.3.1. Lifestyle Diseases
  • 10.3.2. Critical Care
  • 10.3.3. Human Performance Testing
  • 10.3.4. Dysmetabolic Syndrome X
  • 10.3.5. Metabolic Disorders
  • 10.3.6. Other Applications
• 10.4. Market Attractiveness Analysis by Application

11. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Technology

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Technology, 2017 - 2021
• 11.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Technology, 2022 - 2032
  • 11.3.1. VO2 Max Analysis
  • 11.3.2. RMR Analysis
  • 11.3.3. Body Composition Analysis
• 11.4. Market Attractiveness Analysis by Technology

12. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by End User, 2017 - 2021
• 12.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by End User, 2022 - 2032
  • 12.3.1. Hospitals
  • 12.3.2. Laboratories
  • 12.3.3. Sports Training Centers
  • 12.3.4. Gyms
  • 12.3.5. Other End Users
• 12.4. Market Attractiveness Analysis by End User

13. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Region, 2017 - 2021
• 13.3. Current Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Region, 2022 - 2032
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. East Asia
  • 13.3.5. South Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa (MEA)
• 13.4. Market Attractiveness Analysis by Region

14. North America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

• 14.1. Introduction
• 14.2. Pricing Analysis
• 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
• 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
  • 14.4.1. By Country
    • 14.4.1.1. U.S.
    • 14.4.1.2. Canada
  • 14.4.2. By Product
  • 14.4.3. By End User
  • 14.4.4. By Application
  • 14.4.5. By Technology
• 14.5. Market Attractiveness Analysis
  • 14.5.1. By Country
  • 14.5.2. By Product
  • 14.5.3. By End User
  • 14.5.4. By Application
  • 14.5.5. By Technology

15. Latin America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

• 15.1. Introduction
• 15.2. Pricing Analysis
• 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
• 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
  • 15.4.1. By Country
    • 15.4.1.1. Brazil
    • 15.4.1.2. Mexico
    • 15.4.1.3. Rest of Latin America
  • 15.4.2. By Product
  • 15.4.3. By End User
  • 15.4.4. By Application
  • 15.4.5. By Technology
• 15.5. Market Attractiveness Analysis
  • 15.5.1. By Country
  • 15.5.2. By Product
  • 15.5.3. By End User
  • 15.5.4. By Application
  • 15.5.5. By Technology

16. Europe Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

• 16.1. Introduction
• 16.2. Pricing Analysis
• 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
• 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
  • 16.4.1. By Country
    • 16.4.1.1. Germany
    • 16.4.1.2. Italy
    • 16.4.1.3. France
    • 16.4.1.4. U.K.
    • 16.4.1.5. Spain
    • 16.4.1.6. Rest of Europe
  • 16.4.2. By Product
  • 16.4.3. By End User
  • 16.4.4. By Application
  • 16.4.5. By Technology
• 16.5. Market Attractiveness Analysis
  • 16.5.1. By Country
  • 16.5.2. By Product
  • 16.5.3. By End User
  • 16.5.4. By Application
  • 16.5.5. By Technology

17. South Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

• 17.1. Introduction
• 17.2. Pricing Analysis
• 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
• 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
  • 17.4.1. By Country
    • 17.4.1.1. India
    • 17.4.1.2. Thailand
    • 17.4.1.3. Indonesia
    • 17.4.1.4. Malaysia
    • 17.4.1.5. Rest of South Asia
  • 17.4.2. By Product
  • 17.4.3. By End User
  • 17.4.4. By Application
  • 17.4.5. By Technology
• 17.5. Market Attractiveness Analysis
  • 17.5.1. By Country
  • 17.5.2. By Product
  • 17.5.3. By End User
  • 17.5.4. By Application
  • 17.5.5. By Technology

18. East Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

• 18.1. Introduction
• 18.2. Pricing Analysis
• 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
• 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
  • 18.4.1. By Country
    • 18.4.1.1. China
    • 18.4.1.2. Japan
    • 18.4.1.3. South Korea
  • 18.4.2. By Product
  • 18.4.3. By End User
  • 18.4.4. By Application
  • 18.4.5. By Technology
• 18.5. Market Attractiveness Analysis
  • 18.5.1. By Country
  • 18.5.2. By Product
  • 18.5.3. By End User
  • 18.5.4. By Application
  • 18.5.5. By Technology

19. Oceania Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

• 19.1. Introduction
• 19.2. Pricing Analysis
• 19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
• 19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
  • 19.4.1. By Country
    • 19.4.1.1. Australia
    • 19.4.1.2. New Zealand
  • 19.4.2. By Product
  • 19.4.3. By End User
  • 19.4.4. By Application
  • 19.4.5. By Technology
• 19.5. Market Attractiveness Analysis
  • 19.5.1. By Country
  • 19.5.2. By Product
  • 19.5.3. By End User
  • 19.5.4. By Application
  • 19.5.5. By Technology

20. Middle East and Africa Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

• 20.1. Introduction
• 20.2. Pricing Analysis
• 20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
• 20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
  • 20.4.1. By Country
    • 20.4.1.1. GCC Countries
    • 20.4.1.2. Northern Africa
    • 20.4.1.3. South Africa
    • 20.4.1.4. Rest of Middle East and Africa
  • 20.4.2. By Product
  • 20.4.3. By End User
  • 20.4.4. By Application
  • 20.4.5. By Technology
• 20.5. Market Attractiveness Analysis
  • 20.5.1. By Country
  • 20.5.2. By Product
  • 20.5.3. By End User
  • 20.5.4. By Application
  • 20.5.5. By Technology

21. Key Countries' Metabolic Testing Market Analysis 2022-2032

• 21.1. Introduction
  • 21.1.1. Market Value Proportion Analysis, By Key Countries
  • 21.1.2. Global Vs. Country Growth Comparison
• 21.2. U.S. Metabolic Testing Market Analysis
  • 21.2.1. By Product
  • 21.2.2. By End User
  • 21.2.3. By Application
  • 21.2.4. By Technology
• 21.3. Canada Metabolic Testing Market Analysis
  • 21.3.1. By Product
  • 21.3.2. By End User
  • 21.3.3. By Application
  • 21.3.4. By Technology
• 21.4. Mexico Metabolic Testing Market Analysis
  • 21.4.1. By Product
  • 21.4.2. By End User
  • 21.4.3. By Application
  • 21.4.4. By Technology
• 21.5. Brazil Metabolic Testing Market Analysis
  • 21.5.1. By Product
  • 21.5.2. By End User
  • 21.5.3. By Application
  • 21.5.4. By Technology
• 21.6. Germany Metabolic Testing Market Analysis
  • 21.6.1. By Product
  • 21.6.2. By End User
  • 21.6.3. By Application
  • 21.6.4. By Technology
• 21.7. Italy Metabolic Testing Market Analysis
  • 21.7.1. By Product
  • 21.7.2. By End User
  • 21.7.3. By Application
  • 21.7.4. By Technology
• 21.8. U.K. Metabolic Testing Market Analysis
  • 21.8.1. By Product
  • 21.8.2. By End User
  • 21.8.3. By Application
  • 21.8.4. By Technology
• 21.9. China Metabolic Testing Market Analysis
  • 21.9.1. By Product
  • 21.9.2. By End User
  • 21.9.3. By Application
  • 21.9.4. By Technology
• 21.10. Japan Metabolic Testing Market Analysis
  • 21.10.1. By Product
  • 21.10.2. By End User
  • 21.10.3. By Application
  • 21.10.4. By Technology
• 21.11. S. Korea Metabolic Testing Market Analysis
  • 21.11.1. By Product
  • 21.11.2. By End User
  • 21.11.3. By Application
  • 21.11.4. By Technology
• 21.12. India Metabolic Testing Market Analysis
  • 21.12.1. By Product
  • 21.12.2. By End User
  • 21.12.3. By Application
  • 21.12.4. By Technology
• 21.13. Australia and New Zealand Metabolic Testing Market Analysis
  • 21.13.1. By Product
  • 21.13.2. By End User
  • 21.13.3. By Application
  • 21.13.4. By Technology
• 21.14. South Africa Metabolic Testing Market Analysis
  • 21.14.1. By Product
  • 21.14.2. By End User
  • 21.14.3. By Application
  • 21.14.4. By Technology

22. Market Structure Analysis

• 22.1. Market Analysis by Tier of Companies (Metabolic Testing)
• 22.2. Market Concentration
• 22.3. Market Share Analysis of Top Players
• 22.4. Market Presence Analysis
  • 22.4.1. By Regional footprint of Players
  • 22.4.2. Product foot print by Players
  • 22.4.3. Channel Foot Print by Players

23. Competition Analysis

• 23.1. Competition Dashboard
• 23.2. Pricing Analysis by Competition
• 23.3. Competition Benchmarking
• 23.4. Competition Deep Dive
  • 23.4.1. CareFusion Corporation
    • 23.4.1.1. Overview
    • 23.4.1.2. Product Portfolio
    • 23.4.1.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.4.1.4. Sales Footprint
    • 23.4.1.5. Strategy Overview
      • 23.4.1.5.1. Marketing Strategy
      • 23.4.1.5.2. Product Strategy
      • 23.4.1.5.3. Channel Strategy
  • 23.4.2. General Electric Company
    • 23.4.2.1. Overview
    • 23.4.2.2. Product Portfolio
    • 23.4.2.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.4.2.4. Sales Footprint
    • 23.4.2.5. Strategy Overview
      • 23.4.2.5.1. Marketing Strategy
      • 23.4.2.5.2. Product Strategy
      • 23.4.2.5.3. Channel Strategy
  • 23.4.3. Geratherm Medical AG
    • 23.4.3.1. Overview
    • 23.4.3.2. Product Portfolio
    • 23.4.3.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.4.3.4. Sales Footprint
    • 23.4.3.5. Strategy Overview
      • 23.4.3.5.1. Marketing Strategy
      • 23.4.3.5.2. Product Strategy
      • 23.4.3.5.3. Channel Strategy
  • 23.4.4. MGC Diagnostics Corporation
    • 23.4.4.1. Overview
    • 23.4.4.2. Product Portfolio
    • 23.4.4.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.4.4.4. Sales Footprint
    • 23.4.4.5. Strategy Overview
      • 23.4.4.5.1. Marketing Strategy
      • 23.4.4.5.2. Product Strategy
      • 23.4.4.5.3. Channel Strategy

        23.4.5. OSI Systems, Inc.

• 23.4.5.1. Overview
• 23.4.5.2. Product Portfolio
• 23.4.5.3. Profitability by Market Segments (Product/Channel/Region)
• 23.4.5.4. Sales Footprint
• 23.4.5.5. Strategy Overview
  • 23.4.5.5.1. Marketing Strategy
  • 23.4.5.5.2. Product Strategy
  • 23.4.5.5.3. Channel Strategy
• 23.4.6. AEI Technologies, Inc.
  • 23.4.6.1. Overview
  • 23.4.6.2. Product Portfolio
  • 23.4.6.3. Profitability by Market Segments (Product/Channel/Region)
  • 23.4.6.4. Sales Footprint
  • 23.4.6.5. Strategy Overview
    • 23.4.6.5.1. Marketing Strategy
    • 23.4.6.5.2. Product Strategy
    • 23.4.6.5.3. Channel Strategy
• 23.4.7. Cortex Biophysik GmbH
  • 23.4.7.1. Overview
  • 23.4.7.2. Product Portfolio
  • 23.4.7.3. Profitability by Market Segments (Product/Channel/Region)
  • 23.4.7.4. Sales Footprint
  • 23.4.7.5. Strategy Overview
    • 23.4.7.5.1. Marketing Strategy
    • 23.4.7.5.2. Product Strategy
    • 23.4.7.5.3. Channel Strategy
• 23.4.8. COSMED
  • 23.4.8.1. Overview
  • 23.4.8.2. Product Portfolio
  • 23.4.8.3. Profitability by Market Segments (Product/Channel/Region)
  • 23.4.8.4. Sales Footprint
  • 23.4.8.5. Strategy Overview
    • 23.4.8.5.1. Marketing Strategy
    • 23.4.8.5.2. Product Strategy
    • 23.4.8.5.3. Channel Strategy
• 23.4.9. Korr Medical Technologies, Inc.
  • 23.4.9.1. Overview
  • 23.4.9.2. Product Portfolio
  • 23.4.9.3. Profitability by Market Segments (Product/Channel/Region)
  • 23.4.9.4. Sales Footprint
  • 23.4.9.5. Strategy Overview
    • 23.4.9.5.1. Marketing Strategy
    • 23.4.9.5.2. Product Strategy
    • 23.4.9.5.3. Channel Strategy
• 23.4.10. Microlife Medical Home Solutions, Inc.
  • 23.4.10.1. Overview
  • 23.4.10.2. Product Portfolio
  • 23.4.10.3. Profitability by Market Segments (Product/Channel/Region)
  • 23.4.10.4. Sales Footprint
  • 23.4.10.5. Strategy Overview
    • 23.4.10.5.1. Marketing Strategy
    • 23.4.10.5.2. Product Strategy
    • 23.4.10.5.3. Channel Strategy
• 23.4.11. Parvo Medics, Inc.
  • 23.4.11.1. Overview
  • 23.4.11.2. Product Portfolio
  • 23.4.11.3. Profitability by Market Segments (Product/Channel/Region)
  • 23.4.11.4. Sales Footprint
  • 23.4.11.5. Strategy Overview
    • 23.4.11.5.1. Marketing Strategy
    • 23.4.11.5.2. Product Strategy
    • 23.4.11.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology